pmid	doi	year	title	Hugo_Symbol
29311820	10.3389/fnmol.2017.00432	2022	Activation of Autophagy Contributes to Sevoflurane-Induced Neurotoxicity in Fetal Rats.	PTEN
29594222	10.1016/j.ctro.2017.09.006	2022	The impact of the IGF-1 system of cancer cells on radiation response - An <i>in vitro</i> study.	PTEN
31572063	10.1186/s12935-019-0960-5	2022	Ethanol extract of <i>Ligustrum lucidum Ait.</i> leaves suppressed hepatocellular carcinoma in vitro and in vivo.	PTEN
32393046	10.1080/09603123.2020.1757043	2022	The expression of microRNAs and exposure to environmental contaminants related to human health: a review.	PTEN
32431543	10.2147/CMAR.S242903	2022	Clinicopathological Characteristics and Mutational Profiling of Adult T-Cell Lymphoblastic Lymphoma in a Chinese Population.	PTEN
32606772	10.2147/OTT.S250233	2022	HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice.	PTEN
33404293	10.1080/15548627.2020.1871204	2022	BNIP3L-mediated mitophagy is required for mitochondrial remodeling during the differentiation of optic nerve oligodendrocytes.	PTEN
33458694	10.1158/2643-3230.BCD-20-0201	2022	A Tumor Suppressor Enhancer of <i>PTEN</i> in T-cell development and leukemia.	PTEN
34046322		2022	Cytotoxic effects of hydroalcoholic extract of <i>Cuscuta chinensis</i> on PC3 and MCF7 cancer cell lines.	PTEN
34217275	10.1186/s12920-021-01023-9	2022	Hypodiploidy in a pediatric patient of T-cell acute lymphoblastic leukemia: a case report.	PTEN
34396903	10.1080/10428194.2021.1965139	2022	Response to everolimus in a patient with refractory HGBL-NOS harboring multiple genomic aberrations in PTEN.	PTEN
34669944	10.1093/mtomcs/mfab058	2022	Maternal selenium deficiency suppresses proliferation, induces autophagy dysfunction and apoptosis in the placenta of mice.	PTEN
34708625	10.19852/j.cnki.jtcm.2021.05.003	2022	Mechanism of total glucosides from Chishao (Radix Paeoniae Rubra) on proliferation and apoptosis of hepatocellular carcinoma cells via phosphatase and tensin homolog deleted on chromosome ten / phosphatidylinositol 3-kinase / protein kinase B signaling pathway.	PTEN
34750354	10.1038/s41419-021-04353-9	2022	Cooperative miRNA-dependent PTEN regulation drives resistance to BTK inhibition in B-cell lymphoid malignancies.	PTEN
34814054	10.1016/j.tice.2021.101674	2022	Mechanism of IDH1-R132H mutation in T cell acute lymphoblastic leukemia mouse model via the Notch1 pathway.	PTEN
34831026	10.3390/cells10112803	2022	Fluctuations in AKT and PTEN Activity Are Linked by the E3 Ubiquitin Ligase cCBL.	PTEN
34837676	10.22074/cellj.2021.7302	2022	AntagomiR-19a Induced Better Responsiveness to Bortezomib in Myeloma Cell Lines.	PTEN
34956421	10.1155/2021/9956666	2022	miRNA-19b-3p Stimulates Cardiomyocyte Apoptosis Induced by Myocardial Ischemia Reperfusion via Downregulating PTEN.	PTEN
35068334	10.1080/21655979.2022.2026552	2022	Salvianolic acid B alleviates diabetic endothelial and mitochondrial dysfunction by down-regulating apoptosis and mitophagy of endothelial cells.	PTEN
35072573	10.1177/15330338211070689	2022	Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma.	PTEN
35116342	10.21037/tcr-21-2394	2022	miRNA-425-5p enhances diffuse large B cell lymphoma growth by targeting PTEN.	PTEN
35117001	10.21037/tcr.2019.10.04	2022	Prognostic relevance of genetic variations in T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.	PTEN
35117766	10.21037/tcr-20-2071	2022	The expression of SOX9, Tiam1, and PTEN is correlated with angiogenesis and prognosis in gastric cancer.	PTEN
35133871	10.1200/JCO.21.01648	2022	Phase II Study of Copanlisib in Patients With Tumors With <i>PIK3CA</i> Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F.	PTEN
35138919	10.1200/PO.21.00424	2022	Phase II Study of Taselisib in <i>PIK3CA</i>-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.	PTEN
35142981	10.1007/s11033-022-07203-9	2022	Apoptosis induction in human lung and colon cancer cells via impeding VEGF signaling pathways.	PTEN
35184749	10.1186/s12885-022-09275-z	2022	The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis.	PTEN
35185889	10.3389/fimmu.2022.797244	2022	Calcium Signaling Is Impaired in PTEN-Deficient T Cell Acute Lymphoblastic Leukemia.	PTEN
35231988	10.3760/cma.j.issn.0253-2727.2022.01.005	2022	[Mutational spectrum and its prognostic significance in childhood acute lymphoblastic leukemia based on next-generation sequencing technology].	PTEN
35253299	10.1002/gcc.23036	2022	CRLF2 overexpression defines an immature-like subgroup which is rescued through restoration of the PRC2 function in T-cell precursor acute lymphoblastic leukemia.	PTEN
35260738	10.1038/s41598-022-08049-8	2022	PTEN/PI3K/Akt pathway alters sensitivity of T-cell acute lymphoblastic leukemia to L-asparaginase.	PTEN
35279479	10.1016/j.imbio.2022.152205	2022	Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia.	PTEN
35336821	10.3390/biology11030449	2022	Post-Irradiation Thymic Regeneration in B6C3F1 Mice Is Age Dependent and Modulated by Activation of the PI3K-AKT-mTOR Pathway.	PTEN
35411248		2022	PIK-75 overcomes venetoclax resistance <i>via</i> blocking PI3K-AKT signaling and MCL-1 expression in mantle cell lymphoma.	PTEN
35456022	10.3390/cells11081343	2022	Apoptotic and DNA Damage Effect of 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose in Cisplatin-Resistant Non-Small Lung Cancer Cells via Phosphorylation of H<sub>2</sub>AX, CHK2 and p53.	PTEN
35503721	10.7554/eLife.69255	2022	The oncoprotein BCL6 enables solid tumor cells to evade genotoxic stress.	PTEN
35563843	10.3390/cells11091537	2022	Signal Transduction Regulators in Axonal Regeneration.	PTEN
35592654	10.1155/2022/5707504	2022	Effect of miR-144-3p-Targeted Regulation of PTEN on Proliferation, Apoptosis, and Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells under Stretch.	PTEN
35616841	10.1007/s11356-022-20734-9	2022	Cadmium induces apoptosis by miR-9-5p targeting PTEN and regulates the PI3K/AKT pathway in the piglet adrenal gland.	PTEN
35687490	10.1182/bloodadvances.2021006654	2022	Genomic characterization of lymphomas in patients with inborn errors of immunity.	PTEN
35869735	10.14715/cmb/2022.68.2.14	2022	Influences of ALDH2 on Cardiomyocyte Apoptosis in Heart Failure Rats Through Regulating PINK1-Parkin Signaling Pathway-Mediated Mitophagy.	PTEN
35905946	10.1016/j.tox.2022.153275	2022	Ophiopogonin D'-induced mitophagy and mitochondrial damage are associated with dysregulation of the PINK1/Parkin signaling pathway in AC16 cells.	PTEN
35910796	10.7150/thno.72786	2022	Inhibition of acylglycerol kinase sensitizes DLBCL to venetoclax via upregulation of FOXO1-mediated BCL-2 expression.	PTEN
30216493	10.1002/jcb.27081	2021	Upregulated microRNA-132 rescues cardiac fibrosis and restores cardiocyte proliferation in dilated cardiomyopathy through the phosphatase and tensin homolog-mediated PI3K/Akt signal transduction pathway.	PTEN
30304554	10.1002/jcb.27559	2021	Effects of microRNA-494 on proliferation, migration, invasion, and apoptosis of medulloblastoma cells by mediating c-myc through the p38 MAPK signaling pathway.	PTEN
31682844	10.1016/j.jid.2019.08.454	2021	Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma.	PTEN
31712222	10.1101/cshperspect.a036244	2021	PTEN in Regulating Hematopoiesis and Leukemogenesis.	PTEN
31744878	10.1158/1541-7786.MCR-19-0217	2021	HSF1-Mediated Control of Cellular Energy Metabolism and mTORC1 Activation Drive Acute T-Cell Lymphoblastic Leukemia Progression.	PTEN
31752573	10.1080/10428194.2019.1691200	2021	New murine models of aggressive lymphoma.	PTEN
31804006	10.1002/cam4.2757	2021	RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD.	PTEN
31863623	10.1111/jcmm.14782	2021	Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.	PTEN
32004387	10.1111/bjh.16435	2021	Evaluation of the PIK3 pathway in peripheral T-cell lymphoma and NK/T-cell lymphoma.	PTEN
32020591	10.1002/jcp.29544	2021	Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway.	PTEN
32062191	10.1016/j.ceca.2020.102171	2021	Rapamycin inhibits B-cell activating factor (BAFF)-stimulated cell proliferation and survival by suppressing Ca<sup>2+</sup>-CaMKII-dependent PTEN/Akt-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells.	PTEN
32134755	10.1097/PAI.0000000000000839	2021	PTEN Loss and Cyclin A2 Upregulation Define a PI3K/AKT Pathway Activation in Helicobacter pylori-induced MALT and DLBCL Gastric Lymphoma With Features of MALT.	PTEN
32142900	10.1016/j.jmoldx.2020.02.004	2021	Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic Leukemia.	PTEN
32329824	10.26355/eurrev_202004_20810	2021	Effects of miR-32 targeting PTEN on proliferation and apoptosis of myeloma cells.	PTEN
32374309	10.1039/d0fo00019a	2021	Dietary supplementation of l-arginine and N-carbamylglutamate enhances duodenal barrier and mitochondrial functions and suppresses duodenal inflammation and mitophagy in suckling lambs suffering from intrauterine-growth-restriction.	PTEN
32380791	10.3390/cells9051137	2021	hsa-miR-20b-5p and hsa-miR-363-3p Affect Expression of <i>PTEN</i> and <i>BIM</i> Tumor Suppressor Genes and Modulate Survival of T-ALL Cells In Vitro.	PTEN
32423803	10.1016/j.bbrc.2020.03.165	2021	Circular RNA hsa_circ_0008285 inhibits colorectal cancer cell proliferation and migration via the miR-382-5p/PTEN axis.	PTEN
32479694	10.1002/cyto.b.21882	2021	Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK-STAT signaling pathways.	PTEN
32483710	10.1134/S0012496620020106	2021	Changes in the Activity of Genes Involved in the Regulation of Hematopoiesis during Tumorigenesis in Irradiated Mice.	PTEN
32495857	10.26355/eurrev_202005_21306	2021	LncRNA MEG3 inhibits proliferation and promotes apoptosis of synovial cells in rats with knee osteoarthritis by regulating PTEN.	PTEN
32812017	10.1182/blood.2020006996	2021	Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia.	PTEN
32970929	10.1111/ajco.13449	2021	Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance.	PTEN
33000212	10.3892/or.2020.7776	2021	SPAG6 promotes cell proliferation and inhibits apoptosis through the PTEN/PI3K/AKT pathway in Burkitt lymphoma.	PTEN
33037136	10.1158/1535-7163.MCT-19-0973	2021	Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4A.	PTEN
33054126	10.3324/haematol.2020.262659	2021	&lt;i&gt;CDKN2A&lt;/i&gt; deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS).	PTEN
33082322	10.1038/s41419-020-03098-1	2021	Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem cell leukemia/lymphoma syndrome.	PTEN
33085743	10.1093/abbs/gmaa100	2021	NO66 overexpression rescues ethanol-induced cell apoptosis in human AC16 cardiomyocytes by suppressing PTEN and activating the PI3K/Akt signaling.	PTEN
33128318	10.1111/cas.14716	2021	Pathophysiological significance of N-myc downstream-regulated gene 2 in cancer development through protein phosphatase 2A phosphorylation regulation.	PTEN
33154951	10.3389/fonc.2020.591577	2021	Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies.	PTEN
33179084	10.3892/mmr.2020.11666	2021	Effects and mechanism of microRNA‑218 against lung cancer.	PTEN
33191568	10.1002/onco.13595	2021	More Insights on the Use of γ-Secretase Inhibitors in Cancer Treatment.	PTEN
33436855	10.1038/s41598-020-80613-6	2021	Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia.	PTEN
33515421	10.1007/s12094-020-02520-6	2021	Downregulation of HOXA11 enhances endometrial cancer malignancy and cisplatin resistance via activating PTEN/AKT signaling pathway.	PTEN
33561953	10.3390/cancers13040650	2021	Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies.	PTEN
33634864	10.1002/ijc.33527	2021	Deleterious point mutations in T-cell acute lymphoblastic leukemia: Mechanistic insights into leukemogenesis.	PTEN
33651821	10.1371/journal.pone.0247394	2021	IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3.	PTEN
33724154	10.1080/21505594.2021.1899674	2021	Pathogenicity and virulence of Japanese encephalitis virus: Neuroinflammation and neuronal cell damage.	PTEN
33790574	10.2147/OTT.S189032	2021	Oral PI3K-δ,γ Inhibitor for the Management of People with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: A Narrative Review on Duvelisib.	PTEN
33813280	10.1016/j.bbrc.2021.03.081	2021	Nuclear PTEN deficiency and heterozygous PTEN loss have distinct impacts on brain and lymph node size.	PTEN
33843428	10.1080/10428194.2021.1913148	2021	SPAG6-silencing enhances decitabine-induced apoptosis and demethylation of PTEN in SKM-1 cells and in a xenograft mouse model.	PTEN
33898103	10.1016/j.omtn.2021.03.011	2021	Cell death pathways and viruses: Role of microRNAs.	PTEN
33941203	10.1186/s13045-021-01068-4	2021	Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL.	PTEN
33966404	10.21037/apm-21-604	2021	microRNA-181a promotes the proliferation of hypertrophic scar fibroblasts and inhibits their apoptosis via targeting phosphatase and tensin homolog.	PTEN
34061780	10.1172/JCI146893	2021	TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies.	PTEN
34118770	10.1016/j.esmoop.2021.100187	2021	Clinical benefits of precision medicine in treating solid cancers: European Society of Medical Oncology-Magnitude of Clinical Benefit Scale score-based analysis.	PTEN
34166762	10.1016/j.neuroscience.2021.06.021	2021	Phosphatase and Tensin Homolog Deleted on Chromosome Ten Knockdown Attenuates Cognitive Deficits by Inhibiting Neuroinflammation in a Mouse Model of Perioperative Neurocognitive Disorder.	PTEN
34488159	10.1016/j.envpol.2021.118036	2021	Quercetin antagonizes imidacloprid-induced mitochondrial apoptosis through PTEN/PI3K/AKT in grass carp hepatocytes.	PTEN
34589395	10.1016/j.apsb.2020.12.020	2021	Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.	PTEN
34624316	10.1016/j.jbc.2021.101172	2021	Identification of Rac guanine nucleotide exchange factors promoting Lgl1 phosphorylation in glioblastoma.	PTEN
34729049	10.4103/jcar.jcar_14_21	2021	Molecular characterization of lung carcinomas: A study on diagnostic, predictive, and prognostic markers using immunohistochemical analysis at a Tertiary Care Center in Uttarakhand, India.	PTEN
34771656	10.3390/cancers13215493	2021	High Expression of <i>PPM1D</i> Induces Tumors Phenotypically Similar to <i>TP53</i> Loss-of-Function Mutations in Mice.	PTEN
27698880	10.3892/ol.2016.4943	2020	Anticancer effect of deoxypodophyllotoxin induces apoptosis of human prostate cancer cells.	PTEN
28280620	10.21037/jgo.2017.01.14	2020	Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis.	PTEN
28539722	10.4103/0973-1296.204618	2020	Effect of <i>Helix aspersa</i> extract on TNFα, NF-κB and some tumor suppressor genes in breast cancer cell line Hs578T.	PTEN
28943948	10.3892/ol.2017.6721	2020	Analysis of the expression level and methylation of tumor protein p53, phosphatase and tensin homolog and mutS homolog 2 in N-methyl-N-nitrosourea-induced thymic lymphoma in C57BL/6 mice.	PTEN
29312508		2020	Curcumin combined with glycyrrhetinic acid inhibits the development of hepatocellular carcinoma cells by down-regulating the PTEN/PI3K/AKT signalling pathway.	PTEN
29805582	10.3892/ol.2018.8377	2020	Effects of aspirin on proliferation, invasion and apoptosis of Hep-2 cells via the PTEN/AKT/NF-κB/survivin signaling pathway.	PTEN
29896263	10.3892/etm.2018.6191	2020	Nimesulide inhibits proliferation and induces apoptosis of pancreatic cancer cells by enhancing expression of PTEN.	PTEN
30013659	10.3892/ol.2018.8905	2020	miRNA-29a inhibits colon cancer growth by regulation of the PTEN/Akt/GSK3β and Wnt/β-catenin signaling pathways.	PTEN
30233642	10.3389/fgene.2018.00353	2020	Early Onset Multiple Primary Tumors in Atypical Presentation of Cowden Syndrome Identified by Whole-Exome-Sequencing.	PTEN
30307363	10.1080/15384047.2018.1523857	2020	Successful implementation of genomically based treatment of chemotherapy refractory peripheral T-cell lymphoma (PTCL).	PTEN
30344696	10.3892/etm.2018.6710	2020	MicroRNA-423 promotes proliferation, migration and invasion and induces chemoresistance of endometrial cancer cells.	PTEN
30355676	10.1158/1541-7786.MCR-18-0582	2020	<i>Sleeping Beauty</i> Screen Identifies <i>RREB1</i> and Other Genetic Drivers in Human B-cell Lymphoma.	PTEN
30431147	10.1111/bjd.17425	2020	Unilesional mycosis fungoides is associated with increased expression of microRNA-17~92 and T helper 1 skewing.	PTEN
30591655	10.3390/cancers11010023	2020	Effects of SAHA and EGCG on Growth Potentiation of Triple-Negative Breast Cancer Cells.	PTEN
30657567	10.26355/eurrev_201901_16771	2020	Influences of LncRNA SNHG20 on proliferation and apoptosis of glioma cells through regulating the PTEN/PI3K/AKT signaling pathway.	PTEN
30679990	10.3892/etm.2018.7087	2020	MicroRNA-146b induces the PI3K/Akt/NF-κB signaling pathway to reduce vascular inflammation and apoptosis in myocardial infarction by targeting PTEN.	PTEN
30684308	10.1111/vco.12460	2020	Canine CD4+ T-cell lymphoma identified by flow cytometry exhibits a consistent histomorphology and gene expression profile.	PTEN
30701029	10.18632/oncotarget.26514	2020	Targeting protein kinase CK2 and CDK4/6 pathways with a multi-kinase inhibitor ON108110 suppresses pro-survival signaling and growth in mantle cell lymphoma and T-acute lymphoblastic leukemia.	PTEN
30783438	10.3892/etm.2018.7112	2020	Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells <i>in vitro</i> and <i>in vivo</i>, and increases chemosensitivity to 5-fluorouracil and gemcitabine.	PTEN
30809599	10.1016/j.ncrna.2018.08.001	2020	Relations between approved platinum drugs and non-coding RNAs in mesothelioma.	PTEN
30809600	10.1016/j.ncrna.2018.11.001	2020	Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma.	PTEN
30859901	10.1080/15548627.2019.1591672	2020	Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation.	PTEN
30861992	10.3390/foods8030093	2020	Preventive Effect of <i>Lactobacillus fermentum</i> CQPC08 on 4-Nitroquineline-1-Oxide Induced Tongue Cancer in C57BL/6 Mice.	PTEN
30886885	10.1016/j.gore.2019.02.007	2020	Endometrial cancer arising after complete remission of uterine malignant lymphoma: A case report and mutation analysis.	PTEN
30899409		2020	Dysregulated expressions of PTEN, NF-κB, WWP2, p53 and c-Myc in different subtypes of B cell lymphoma and reactive follicular hyperplasia.	PTEN
30946933	10.1016/j.humpath.2019.03.004	2020	The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement.	PTEN
30950667	10.1080/10428194.2019.1597270	2020	Gene mutations and pretransplant minimal residual disease predict risk of relapse in adult patients after allogeneic hematopoietic stem-cell transplantation for T cell acute lymphoblastic leukemia.	PTEN
30995468	10.1016/j.celrep.2019.03.067	2020	Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation.	PTEN
31056348	10.1016/j.clml.2019.03.015	2020	Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study.	PTEN
31086597	10.3892/etm.2019.7464	2020	Expression of miRNA-214 in the sera of elderly patients with acute myocardial infarction and its effect on cardiomyocyte apoptosis.	PTEN
31205619	10.1016/j.csbj.2019.03.006	2020	Application of PD-1 Blockade in Cancer Immunotherapy.	PTEN
31257073	10.1016/j.ccell.2019.05.015	2020	RAC1<sup>P29S</sup> Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance.	PTEN
31257508	10.3892/mmr.2019.10445	2020	miR‑29 promotes the proliferation of cultured rat neural stem/progenitor cells via the PTEN/AKT signaling pathway.	PTEN
31270080	10.1182/bloodadvances.2018028993	2020	Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia.	PTEN
31383760	10.1073/pnas.1905239116	2020	Repurposing dasatinib for diffuse large B cell lymphoma.	PTEN
31389595	10.26355/eurrev_201908_18661	2020	Effect of miR-26a on diabetic rats with myocardial injury by targeting PTEN.	PTEN
31473762	10.12659/MSM.916461	2020	Tenacigenin B Has Anti-Tumor Effect in Lymphoma by In Vitro and In Vivo Study.	PTEN
31571345	10.1002/pbc.28025	2020	Next-generation sequencing of PTEN mutations for monitoring minimal residual disease in T-cell acute lymphoblastic leukemia.	PTEN
31599421	10.26355/eurrev_201909_19012	2020	Polyoxometalate SbW9 regulates proliferation and apoptosis of NSCLC cells via PTEN-dependent AKT signaling pathway.	PTEN
31622281	10.1172/jci.insight.131434	2020	A unique mutator phenotype reveals complementary oncogenic lesions leading to acute leukemia.	PTEN
31680766	10.4196/kjpp.2019.23.6.449	2020	Long non-coding RNA T-cell leukemia/lymphoma 6 serves as a sponge for miR-21 modulating the cell proliferation of retinoblastoma through PTEN.	PTEN
31719683	10.1038/s41375-019-0628-0	2020	Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma.	PTEN
31744268	10.4274/tjh.galenos.2019.2019.0282	2020	<i>PTEN</i> and <i>AKT1</i> Variations in Childhood T-Cell Acute Lymphoblastic Leukemia	PTEN
31765670	10.1016/j.bbamcr.2019.118615	2020	Novel PRMT5-mediated arginine methylations of HSP90A are essential for maintenance of HSP90A function in NDRG2<sup>low</sup> ATL and various cancer cells.	PTEN
31780660	10.1038/s41408-019-0259-8	2020	Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma.	PTEN
31801949	10.1038/s41419-019-2158-0	2020	Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignancies.	PTEN
31922234	10.3892/or.2020.7457	2020	Role and mechanism of PTEN in Burkitt's lymphoma.	PTEN
31926247	10.1016/j.lfs.2019.117249	2020	Antitumor effects of rafoxanide in diffuse large B cell lymphoma via the PTEN/PI3K/Akt and JNK/c-Jun pathways.	PTEN
31999420	10.18388/abp.2020_2901	2020	The effects of clofarabine in ALL inhibition through DNA methylation regulation.	PTEN
32012328	10.1002/hon.2718	2020	High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas.	PTEN
32038991	10.3389/fonc.2020.00023	2020	The Genetic and Molecular Basis for Canine Models of Human Leukemia and Lymphoma.	PTEN
32063363	10.1016/j.bbrc.2020.02.021	2020	Miltefosine suppression of Pten null T-ALL leukemia via β-catenin degradation through inhibition of pT308-Akt and TGFβ1/Smad3.	PTEN
32186011		2020	Protective effect and mechanisms of Weining granule on N-methyl-N'-nitro-N- nitrosoguanidine-induced gastric cancer in rats.	PTEN
32565964	10.3892/ol.2020.11552	2020	Comprehensive characterization of driver genes in diffuse large B cell lymphoma.	PTEN
32670512	10.4084/MJHID.2020.034	2020	Burkitt Lymphoma as Fourth Neoplasia in a Patient Affected by Cowden Syndrome with a Novel PTEN Germline Pathogenic Variant.	PTEN
32726924	10.3390/cancers12082067	2020	Biology of Oestrogen-Receptor Positive Primary Breast Cancer in Older Women with Utilisation of Core Needle Biopsy Samples and Correlation with Clinical Outcome.	PTEN
32804454	10.1097/PAS.0000000000001512	2020	Colorectal Adenocarcinomas Harboring ALK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 12 Cases and Review of the Literature.	PTEN
32871937	10.1097/MD.0000000000021938	2020	Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report.	PTEN
32973533	10.3389/fphar.2020.01326	2020	Hesperetin Promotes Cisplatin-Induced Apoptosis of Gastric Cancer <i>In Vitro</i> and <i>In Vivo</i> by Upregulating <i>PTEN</i> Expression.	PTEN
33109561	10.21873/anticanres.14644	2020	3EZ, 20Ac-ingenol-induced Apoptosis in Chemoresistant Cancers With Cyclin D1 Accumulation.	PTEN
33283700	10.19746/j.cnki.issn.1009-2137.2020.06.001	2020	[Gene Mutation in Acute Lymphoblastic Leukemia by DNA Sequencing].	PTEN
33283722	10.19746/j.cnki.issn.1009-2137.2020.06.023	2020	[Effects of Soluble CD40 Ligand on Non-Hodgkin Lymphoma Cells and Its Relative Mechanism].	PTEN
28391632	10.1111/1346-8138.13851	2019	Multiple keratotic papules and plaques on the trunk in Cowden's disease with MALT lymphoma.	PTEN
28747658	10.1038/s41598-017-06848-y	2019	A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17.	PTEN
29029507	10.18632/oncotarget.19889	2019	PIK3CA amplification and PTEN loss in diffused large B-cell lymphoma.	PTEN
29051182	10.1182/blood-2017-04-778829	2019	Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia.	PTEN
29127491	10.1007/s00540-017-2431-2	2019	Pink1 attenuates propofol-induced apoptosis and oxidative stress in developing neurons.	PTEN
29151585	10.1038/leu.2017.328	2019	Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system.	PTEN
29287955	10.1016/j.jbior.2017.12.001	2019	Remodeling of Ca<sup>2+</sup> signaling in cancer: Regulation of inositol 1,4,5-trisphosphate receptors through oncogenes and tumor suppressors.	PTEN
29330147	10.1158/0008-5472.CAN-17-2457	2019	Genetic Ablation of <i>Rbm38</i> Promotes Lymphomagenesis in the Context of Mutant p53 by Downregulating PTEN.	PTEN
29367757	10.1038/s41388-017-0091-1	2019	The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase.	PTEN
29399633	10.1126/sciadv.aar5701	2019	Discrete roles and bifurcation of PTEN signaling and mTORC1-mediated anabolic metabolism underlie IL-7-driven B lymphopoiesis.	PTEN
29514083	10.1016/j.celrep.2018.02.049	2019	PI3K/Akt Cooperates with Oncogenic Notch by Inducing Nitric Oxide-Dependent Inflammation.	PTEN
29556024	10.1038/s41375-018-0046-8	2019	The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia.	PTEN
29567770	10.3324/haematol.2018.188359	2019	Fit αβ T-cell receptor suppresses leukemogenesis of Pten-deficient thymocytes.	PTEN
29666304	10.1158/1078-0432.CCR-17-3004	2019	Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas.	PTEN
29844571	10.1038/s41388-018-0325-x	2019	Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.	PTEN
29846633	10.1210/jc.2017-01845	2019	Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts.	PTEN
29914415	10.1186/s12885-018-4525-0	2019	MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB.	PTEN
29937999	10.18632/oncotarget.25463	2019	Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma.	PTEN
29938780	10.1111/bjh.15449	2019	The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols.	PTEN
30005850	10.1016/j.cancergen.2018.04.119	2019	Challenges in next generation sequencing analysis of somatic mutations in transplant patients.	PTEN
30106086	10.3892/ijmm.2018.3814	2019	MicroRNA‑214 suppresses propofol‑induced neuroapoptosis through activation of phosphoinositide 3‑kinase/protein kinase B signaling by targeting phosphatase and tensin homolog expression.	PTEN
30120912	10.1002/cncr.31589	2019	Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy.	PTEN
30296359	10.1002/iub.1944	2019	MCL1 gene silencing promotes senescence and apoptosis of glioma cells via inhibition of the PI3K/Akt signaling pathway.	PTEN
30359076	10.1152/ajpheart.00487.2018	2019	BMI1 promotes cardiac fibrosis in ischemia-induced heart failure via the PTEN-PI3K/Akt-mTOR signaling pathway.	PTEN
30373357	10.3760/cma.j.issn.0253-2727.2018.10.010	2019	[Expressions and prognostic significance of PTEN and PD-1 protein in patients with classical Hodgkin's lymphoma].	PTEN
30412053	10.7554/eLife.38314	2019	T-ALL leukemia stem cell 'stemness' is epigenetically controlled by the master regulator SPI1.	PTEN
30413411	10.1158/0008-5472.CAN-18-1889	2019	Loss of the BCR-FGFR1 GEF Domain Suppresses RHOA Activation and Enhances B-Lymphomagenesis in Mice.	PTEN
30466748	10.1016/j.beha.2018.10.001	2019	Can one target T-cell ALL?	PTEN
30518749	10.1038/s41419-018-1212-7	2019	Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome.	PTEN
30518812	10.1038/s41375-018-0305-8	2019	Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance.	PTEN
30524445	10.3389/fimmu.2018.02715	2019	The c-Myc/miR17-92/PTEN Axis Tunes PI3K Activity to Control Expression of Recombination Activating Genes in Early B Cell Development.	PTEN
30563911	10.1101/gr.241141.118	2019	Human papillomavirus and the landscape of secondary genetic alterations in oral cancers.	PTEN
30612403	10.3760/cma.j.issn.0253-2727.2018.12.008	2019	[PRDM1 expression and its relationship with PI3K/AKT pathway activation in extranodal NK/T cell lymphoma-nasal type].	PTEN
30614545	10.1002/ajh.25396	2019	PTEN abnormalities predict poor outcome in children with T-cell acute lymphoblastic leukemia treated according to ALL IC-BFM protocols.	PTEN
30721949	10.1093/carcin/bgz013	2019	Mutational landscape of T-cell lymphoma in mice lacking the DNA mismatch repair gene Mlh1: no synergism with ionizing radiation.	PTEN
30763910	10.1016/j.neo.2019.01.004	2019	Comprehensive Investigation of miRNome Identifies Novel Candidate miRNA-mRNA Interactions Implicated in T-Cell Acute Lymphoblastic Leukemia.	PTEN
30782609	10.1182/blood-2018-09-872549	2019	Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.	PTEN
30816511	10.3892/or.2019.7015	2019	Tripartite motif‑containing 11 regulates the proliferation and apoptosis of breast cancer cells.	PTEN
30841886	10.1186/s12885-019-5411-0	2019	Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.	PTEN
30845295		2019	Clinical, morphological and immunohistochemical survey in different types of endometriosis.	PTEN
30998151	10.19746/j.cnki.issn.1009-2137.2019.02.021	2019	[Exploration of the Role of Tumor Suppressor Genes Foxo1 and PTEN in the Tumorigenesis of Mouse Natural Killer-Cell Lymphoma].	PTEN
31018830	10.1177/1010428319846803	2019	Mesenchymal stem cells targeting PI3K/AKT pathway in leukemic model.	PTEN
31038023	10.1080/10799893.2019.1585452	2019	miR-21 promotes proliferation and inhibits apoptosis of hepatic stellate cells through targeting PTEN/PI3K/AKT pathway.	PTEN
31115571	10.3892/mmr.2019.10227	2019	Formaldehyde induces the apoptosis of BMCs of BALB/c mice via the PTEN/PI3K/Akt signal transduction pathway.	PTEN
31839029	10.19746/j.cnki.issn.1009-2137.2019.06.003	2019	[Expression Level and Clinical Value of PTEN Gene in Patients with Acute T Lymphocytic Leukemia].	PTEN
26642854	10.1101/sqb.2015.80.027631	2018	The Evolution of Tumors in Mice and Humans with Germline p53 Mutations.	PTEN
27102345	10.1038/modpathol.2016.79	2018	Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.	PTEN
27172795	10.18632/oncotarget.9237	2018	Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.	PTEN
27736268	10.1080/10428194.2016.1239257	2018	Iron chelation: an adjuvant therapy to target metabolism, growth and survival of murine PTEN-deficient T lymphoma and human T lymphoblastic leukemia/lymphoma.	PTEN
27756877	10.18632/oncotarget.12654	2018	Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.	PTEN
27779101	10.18632/oncotarget.12631	2018	A four-gene signature predicts survival in clear-cell renal-cell carcinoma.	PTEN
28002793	10.18632/oncotarget.14008	2018	Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.	PTEN
28107044	10.1080/01635581.2017.1267775	2018	Quercetin Attenuates Cell Survival, Inflammation, and Angiogenesis via Modulation of AKT Signaling in Murine T-Cell Lymphoma.	PTEN
28351340	10.1089/thy.2016.0254	2018	Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases.	PTEN
28446316	10.7534/j.issn.1009-2137.2017.02.050	2018	[Prognostic Value of Recurrent Molecular Genetics and Epigenetics Abnormity in T Lymphoblastic Lymphoma / Leukemia -Review].	PTEN
28465297	10.1158/1541-7786.MCR-16-0305	2018	Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences.	PTEN
28489605	10.18632/oncotarget.17383	2018	Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome.	PTEN
28498459	10.3892/mmr.2017.6568	2018	Inhibitors of PARP-1 exert inhibitory effects on the biological characteristics of hepatocellular carcinoma cells in vitro.	PTEN
28544358	10.1111/ajco.12690	2018	The expression pattern of Bcl11a, Mdm2 and Pten genes in B-cell acute lymphoblastic leukemia.	PTEN
28633365	10.1093/annonc/mdx289	2018	Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma.	PTEN
28716817	10.1158/1535-7163.MCT-17-0141	2018	PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature.	PTEN
29043551	10.1007/s12185-017-2359-1	2018	MAGI-1 expression is decreased in several types of human T-cell leukemia cell lines, including adult T-cell leukemia.	PTEN
29115462	10.3892/mmr.2017.7903	2018	Hedyotis diffusa Willd inhibits proliferation and induces apoptosis of 5‑FU resistant colorectal cancer cells by regulating the PI3K/AKT signaling pathway.	PTEN
29115608	10.3892/mmr.2017.7886	2018	MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer.	PTEN
29127587	10.1007/s40265-017-0838-6	2018	Copanlisib: First Global Approval.	PTEN
29143824	10.1038/nature24649	2018	PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis.	PTEN
29172833	10.1080/0284186X.2017.1404634	2018	A systematic review of targeted agents for non-small cell lung cancer.	PTEN
29179029	10.1016/j.leukres.2017.08.007	2018	3EZ, 20Ac-ingenol induces cell-specific apoptosis in cyclin D1 over-expression through the activation of ATR and downregulation of p-Akt.	PTEN
29185784	10.1089/dna.2017.3922	2018	miR-21 Inhibitors Modulate Biological Functions of Gastric Cancer Cells via PTEN/PI3K/mTOR Pathway.	PTEN
29207012	10.3892/ijmm.2017.3269	2018	MicroRNA‑30a‑5p suppresses tumor cell proliferation of human renal cancer via the MTDH/PTEN/AKT pathway.	PTEN
29298131	10.1080/13510002.2017.1416773	2018	A systematic review of p53 regulation of oxidative stress in skeletal muscle.	PTEN
29328455	10.3892/mmr.2018.8381	2018	Role of miR-21 in the growth and metastasis of human salivary adenoid cystic carcinoma.	PTEN
29393336	10.3892/ijmm.2018.3433	2018	Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.	PTEN
29397829	10.7534/j.issn.1009-2137.2018.01.020	2018	[Expression and Significance of PTEN and BCL-2 in Acute Myeloid Leukemia].	PTEN
29414597	10.1016/j.bone.2018.01.021	2018	Young female patients with multiple myeloma have low occurrence of osteolytic lesion.	PTEN
29436653	10.3892/mmr.2018.8585	2018	Upregulation of phosphatase and tensin homolog is essential for the effect of 4-aminopyridine on A549/CDDP cells.	PTEN
29734016	10.1016/j.neo.2018.03.002	2018	Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma.	PTEN
29749523	10.3892/mmr.2018.8998	2018	Overexpression of Annexin A1 protects against benzo[a]pyrene‑induced bronchial epithelium injury.	PTEN
29901068	10.3892/ijo.2018.4427	2018	Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma.	PTEN
29920278	10.1016/j.devcel.2018.05.021	2018	Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis.	PTEN
30015974	10.3892/or.2018.6544	2018	Knockdown of NUPR1 inhibits the growth of U266 and RPMI8226 multiple myeloma cell lines via activating PTEN and caspase activation‑dependent apoptosis.	PTEN
30096458	10.1016/j.gene.2018.08.022	2018	BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.	PTEN
30111390	10.7534/j.issn.1009-2137.2018.04.002	2018	[Expression and Significance of PTEN and Survivin in Acute Lymphoblastic Leukemia].	PTEN
30132530	10.3892/mmr.2018.9402	2018	Elevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer.	PTEN
25451263	10.1016/j.bbrc.2014.10.107	2017	Targeting miR-21 sensitizes Ph+ ALL Sup-b15 cells to imatinib-induced apoptosis through upregulation of PTEN.	PTEN
26033966	10.1136/gutjnl-2014-308270	2017	BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling.	PTEN
26616857	10.1038/onc.2015.462	2017	Oncogenic PTEN functions and models in T-cell malignancies.	PTEN
26797410	10.1136/jclinpath-2015-203403	2017	Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases.	PTEN
26989080	10.18632/oncotarget.8031	2017	Identification of differential PI3K pathway target dependencies in T-cell acute lymphoblastic leukemia through a large cancer cell panel screen.	PTEN
27041560	10.1038/onc.2016.86	2017	Targeting CK2-driven non-oncogene addiction in B-cell tumors.	PTEN
27151993	10.3324/haematol.2015.139410	2017	RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.	PTEN
27164089	10.3390/ijms17050683	2017	Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses.	PTEN
27174491	10.1038/leu.2016.83	2017	MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia.	PTEN
27197189	10.1158/0008-5472.CAN-15-2698	2017	Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma.	PTEN
27304073	10.7554/eLife.14709	2017	Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitors.	PTEN
27494022	10.1371/journal.pone.0160686	2017	PI-103 and Quercetin Attenuate PI3K-AKT Signaling Pathway in T- Cell Lymphoma Exposed to Hydrogen Peroxide.	PTEN
27532210	10.1371/journal.pone.0161158	2017	IGF1R Derived PI3K/AKT Signaling Maintains Growth in a Subset of Human T-Cell Acute Lymphoblastic Leukemias.	PTEN
27582570	10.3324/haematol.2016.146381	2017	The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.	PTEN
27600880	10.1007/s00280-016-3151-2	2017	Measures of 6-mercaptopurine and methotrexate maintenance therapy intensity in childhood acute lymphoblastic leukemia.	PTEN
27672108	10.1093/annonc/mdw282	2017	First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas.	PTEN
27717083	10.1002/gcc.22423	2017	T-cell acute lymphoblastic leukemia in infants has distinct genetic and epigenetic features compared to childhood cases.	PTEN
27759908	10.1002/pbc.26266	2017	Translocation t(8;14)(q24;q11) with concurrent PTEN alterations and deletions of STIL/TAL1 and CDKN2A/B in a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis.	PTEN
27775850	10.1111/his.13106	2017	Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS).	PTEN
27796281	10.12659/msm.897306	2017	Epstein-Barr Virus (EBV)-BamHI-A Rightward Transcript (BART)-6 and Cellular MicroRNA-142 Synergistically Compromise Immune Defense of Host Cells in EBV-Positive Burkitt Lymphoma.	PTEN
27830963	10.1080/10428194.2016.1213827	2017	MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma.	PTEN
27878257	10.3892/or.2016.5244	2017	Downregulation of Bmi-1 suppresses epithelial‑mesenchymal transition in melanoma.	PTEN
28178345	10.1371/journal.pone.0171221	2017	PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors.	PTEN
28192480	10.1371/journal.pone.0170771	2017	mTOR activity in AIDS-related diffuse large B-cell lymphoma.	PTEN
28202458	10.1182/blood-2016-12-758599	2017	Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCL.	PTEN
28280276	10.1038/leu.2017.80	2017	Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD.	PTEN
28399347	10.22608/APO.201710	2017	Conjunctival Tumors: Review of Clinical Features, Risks, Biomarkers, and Outcomes--The 2017 J. Donald M. Gass Lecture.	PTEN
28468797	10.1182/blood-2016-11-750174	2017	Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma.	PTEN
28476823	10.21873/anticanres.11595	2017	Prediction of Relapse After Therapy Withdrawal in Women with Endometrial Hyperplasia: A Long-term Follow-up Study.	PTEN
28539671	10.1038/leu.2017.157	2017	Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemia.	PTEN
28546582	10.1038/leu.2017.160	2017	Control of amino acid transport coordinates metabolic reprogramming in T-cell malignancy.	PTEN
28608966	10.1002/cncr.30794	2017	Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy.	PTEN
28646116	10.1182/blood-2016-10-747303	2017	Tonic B-cell receptor signaling in diffuse large B-cell lymphoma.	PTEN
28646488	10.1002/ijc.30848	2017	Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1-driven leukemia/lymphomas.	PTEN
28671688	10.1038/ng.3909	2017	The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia.	PTEN
28703366	10.1002/ptr.5866	2017	Synergistic Effect of TPD7 and Berberine against Leukemia Jurkat Cell Growth through Regulating Ephrin-B2 Signaling.	PTEN
28723738	10.1097/MD.0000000000007111	2017	Phosphatase and tensin homolog (PTEN) is down-regulated in human NK/T-cell lymphoma and corrects with clinical outcomes.	PTEN
28739740	10.21873/anticanres.11841	2017	Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.	PTEN
28816549	10.1080/14728222.2017.1369044	2017	Implications of Bcl-2 and its interplay with other molecules and signaling pathways in prostate cancer progression.	PTEN
28854563	10.1093/carcin/bgx061	2017	Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma.	PTEN
28881619	10.18632/oncotarget.16435	2017	mRNA in exosomas as a liquid biopsy in non-Hodgkin Lymphoma: a multicentric study by the Spanish Lymphoma Oncology Group.	PTEN
28953617	10.1097/MD.0000000000007952	2017	Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma.	PTEN
29131834	10.1371/journal.pone.0187722	2017	Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance.	PTEN
24273277		2016	[Effects of Epstein-Barr virus and cytomegalovirus infection on childhood acute lymphoblastic leukemia gene methylation].	PTEN
25158671	10.1007/s12012-014-9276-9	2016	The effects of high glucose levels on reactive oxygen species-induced apoptosis and involved signaling in human vascular endothelial cells.	PTEN
25430416	10.3109/10428194.2014.990900	2016	Dissecting chronic lymphocytic leukemia microenvironment signals in patients with unmutated disease: microRNA-22 regulates phosphatase and tensin homolog/AKT/FOXO1 pathway in proliferative leukemic cells.	PTEN
25608224	10.3892/mmr.2015.3214	2016	Overexpression of Aiolos in Nalm-6 acute lymphoblastic leukaemia cells reduces apoptosis by suppressing phosphatase and tensin homologue deleted on chromosome 10 and activating the phosphatidylinositol-3-kinase/Akt signalling pathway.	PTEN
25678421	10.1016/j.jcpa.2014.11.008	2016	Reconstruction of canine diffuse large B-cell lymphoma gene regulatory network: detection of functional modules and hub genes.	PTEN
25729885	10.1080/15384047.2015.1019184	2016	Small molecule schweinfurthins selectively inhibit cancer cell proliferation and mTOR/AKT signaling by interfering with trans-Golgi-network trafficking.	PTEN
25793663	10.1080/15384047.2015.1018495	2016	Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.	PTEN
25801032	10.1016/j.celrep.2015.02.056	2016	FAK mediates a compensatory survival signal parallel to PI3K-AKT in PTEN-null T-ALL cells.	PTEN
25867342	10.4238/2015.March.20.6	2016	Effect of TIEG1 on apoptosis and expression of Bcl-2/Bax and Pten in leukemic cell lines.	PTEN
25869207	10.18632/oncotarget.3524	2016	PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia.	PTEN
25871383	10.18632/oncotarget.3295	2016	PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors.	PTEN
25880371	10.1080/15384047.2015.1026472	2016	Bmi-1 expression modulates non-small cell lung cancer progression.	PTEN
25903014	10.1186/s13045-015-0138-0	2016	Deep sequencing and SNP array analyses of pediatric T-cell acute lymphoblastic leukemia reveal NOTCH1 mutations in minor subclones and a high incidence of uniparental isodisomies affecting CDKN2A.	PTEN
25907832	10.1016/j.ajpath.2015.01.025	2016	The PTEN-AKT-mTOR/RICTOR Pathway in Nasal Natural Killer Cell Lymphoma Is Activated by miR-494-3p via PTEN But Inhibited by miR-142-3p via RICTOR.	PTEN
25909227	10.18632/oncotarget.3729	2016	MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.	PTEN
25929783	10.1007/s11418-015-0915-7	2016	PTEN over-expression by resveratrol in acute lymphoblastic leukemia cells along with suppression of AKT/PKB and ERK1/2 in genotoxic stress.	PTEN
26030190	10.1080/15384101.2015.1041692	2016	Nuclear localized Akt enhances breast cancer stem-like cells through counter-regulation of p21(Waf1/Cip1) and p27(kip1).	PTEN
26080839	10.1158/1078-0432.CCR-15-0114	2016	Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235.	PTEN
26125582	10.1371/journal.pone.0130666	2016	Genetic Analysis of T Cell Lymphomas in Carbon Ion-Irradiated Mice Reveals Frequent Interstitial Chromosome Deletions: Implications for Second Cancer Induction in Normal Tissues during Carbon Ion Radiotherapy.	PTEN
26205622	10.1111/bjh.13613	2016	Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia.	PTEN
26220040	10.1038/leu.2015.206	2016	Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.	PTEN
26235020	10.3171/2015.5.FOCUS15143	2016	The genetic basis of intradural spinal tumors and its impact on clinical treatment.	PTEN
26244872	10.18632/oncotarget.4111	2016	Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.	PTEN
26252081	10.3892/ijmm.2015.2305	2016	The combined use of miRNAs and mRNAs as biomarkers for the diagnosis of papillary thyroid carcinoma.	PTEN
26269411	10.1038/srep12841	2016	Loss of NDRG2 enhanced activation of the NF-κB pathway by PTEN and NIK phosphorylation for ATL and other cancer development.	PTEN
26365182	10.1016/j.celrep.2015.08.034	2016	Off-Target V(D)J Recombination Drives Lymphomagenesis and Is Escalated by Loss of the Rag2 C Terminus.	PTEN
26377837	10.1101/gr.194449.115	2016	Exome sequencing of lymphomas from three dog breeds reveals somatic mutation patterns reflecting genetic background.	PTEN
26390244	10.1038/nm.3955	2016	Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia.	PTEN
26439034		2016	Overexpression of microRNA-21 in peripheral blood mononuclear cells of patients with B-cell non-Hodgkin's lymphoma is associated with disease stage and treatment outcome.	PTEN
26468640	10.1002/pbc.25796	2016	Breast Cancer and Non-Hodgkin Lymphoma in a Young Male with Cowden Syndrome.	PTEN
26551667	10.1038/ng.3442	2016	The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.	PTEN
26578780	10.1073/pnas.1514748112	2016	Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.	PTEN
26637164		2016	Identification of Top-ranked Proteins within a Directional Protein Interaction Network using the PageRank Algorithm: Applications in Humans and Plants.	PTEN
26644537	10.1200/JCO.2015.61.5385	2016	Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.	PTEN
26655726	10.18632/aging.100855	2016	The PTEN tumor suppressor gene and its role in lymphoma pathogenesis.	PTEN
26773036	10.1182/blood-2015-09-669036	2016	Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies.	PTEN
26823817		2016	Evaluation of AKT phosphorylation and PTEN loss and their correlation with the resistance of rituximab in DLBCL.	PTEN
26830028	10.1186/s13000-016-0468-4	2016	CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival.	PTEN
26852652	10.1016/j.bcmd.2015.11.006	2016	ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia.	PTEN
26861608	10.1093/annonc/mdv624	2016	A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas.	PTEN
26864725	10.1080/15384101.2015.1128191	2016	Targeting NOTCH1 in T-ALL: Starving the dragon.	PTEN
26936314	10.3892/mmr.2016.4904	2016	Knockdown of ephrin receptor A7 suppresses the proliferation and metastasis of A549 human lung cancer cells.	PTEN
26974310	10.1038/nm.4062	2016	PTEN opposes negative selection and enables oncogenic transformation of pre-B cells.	PTEN
27050585	10.1038/nm.4083	2016	PTEN enables the development of pre-B acute lymphoblastic leukemia.	PTEN
27062783		2016	[Expression of MiR-130a in Serum Samples of Patients with Epithelial Ovarian Cancer and Its Association with Platinum Resistance].	PTEN
27186313		2016	microRNA-22 attenuates neuronal cell apoptosis in a cell model of traumatic brain injury.	PTEN
22491738	10.3324/haematol.2011.059030	2015	The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia.	PTEN
23979650	10.1007/s10014-013-0158-9	2015	Differential diagnosis of small cell glioblastoma and anaplastic oligodendroglioma: a case report of an elderly man.	PTEN
24561254	10.1016/j.celrep.2014.01.030	2015	PTEN C-terminal deletion causes genomic instability and tumor development.	PTEN
24561792	10.3324/haematol.2013.096438	2015	Adult B-cell acute lymphoblastic leukemia cells display decreased PTEN activity and constitutive hyperactivation of PI3K/Akt pathway despite high PTEN protein levels.	PTEN
24676391	10.3892/mmr.2014.2068	2015	microRNA-21 protects against ischemia-reperfusion and hypoxia-reperfusion-induced cardiocyte apoptosis via the phosphatase and tensin homolog/Akt-dependent mechanism.	PTEN
24731196	10.1089/jir.2013.0061	2015	Modulation of the sensitivity of Jurkat T-cells to inhibition of protein synthesis by tumor necrosis factor α-related apoptosis-inducing ligand.	PTEN
24739416	10.4161/cc.28895	2015	The TRAF3 adaptor protein drives proliferation of anaplastic large cell lymphoma cells by regulating multiple signaling pathways.	PTEN
24778134	10.1158/2326-6066.CIR-13-0065	2015	Novel mechanism of tumor suppression by polarity gene discs large 1 (DLG1) revealed in a murine model of pediatric B-ALL.	PTEN
24949116	10.1155/2014/457154	2015	Response to rotenone is glucose-sensitive in a model of human acute lymphoblastic leukemia: involvement of oxidative stress mechanism, DJ-1, Parkin, and PINK-1 proteins.	PTEN
24983247	10.1371/journal.pone.0101283	2015	Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2A, PTEN, and SMARCB1.	PTEN
25080849	10.1111/ejh.12427	2015	B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells.	PTEN
25096023	10.1186/1471-2407-14-565	2015	Constitutive AKT activation in follicular lymphoma.	PTEN
25201756	10.1016/j.exphem.2014.08.006	2015	Rictor/mammalian target of rapamycin 2 regulates the development of Notch1 induced murine T-cell acute lymphoblastic leukemia via forkhead box O3.	PTEN
25267489	10.1111/exd.12547	2015	In situ assessment of PI3K and PTEN alterations in mycosis fungoides: correlation with clinicopathological features.	PTEN
25281505	10.3324/haematol.2014.110742	2015	Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia.	PTEN
25287161	10.1158/0008-5472.CAN-14-1470	2015	Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemia.	PTEN
25347953	10.1038/ncomms6217	2015	RNAi-based functional selection identifies novel cell migration determinants dependent on PI3K and AKT pathways.	PTEN
25444908	10.1016/j.canlet.2014.11.025	2015	β-Arrestin1 promotes the self-renewal of the leukemia-initiating cell-enriched subpopulation in B-lineage acute lymphoblastic leukemia related to DNMT1 activity.	PTEN
25452272	10.1101/gad.252148.114	2015	The evolution of thymic lymphomas in p53 knockout mice.	PTEN
25477498	10.1182/blood-2014-04-571372	2015	Suppression of T-cell lymphomagenesis in mice requires PTEN phosphatase activity.	PTEN
25482130	10.1038/leu.2014.338	2015	L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia.	PTEN
25526784	10.1089/ars.2014.6204	2015	Hypoxia activation of mitophagy and its role in disease pathogenesis.	PTEN
25541152	10.1038/leu.2014.351	2015	MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.	PTEN
25543482	10.7534/j.issn.1009-2137.2014.06.019	2015	[Expression of MiRNA-21 in diffuse large B cell lymphoma and its significance].	PTEN
25551567	10.4161/15548627.2014.984270	2015	Autophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine.	PTEN
25587943	10.1080/15592294.2014.1003746	2015	Epigenetic regulation in human melanoma: past and future.	PTEN
25634356	10.1038/jid.2015.27	2015	The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous B-Cell Lymphoma Progression.	PTEN
25734830	10.1097/CAD.0000000000000223	2015	Doxorubicin induces apoptosis in Jurkat cells by mitochondria-dependent and mitochondria-independent mechanisms under normoxic and hypoxic conditions.	PTEN
25740104	10.3324/haematol.2014.118562	2015	T-ALL: ALL a matter of Translation?	PTEN
25938254	10.3791/52599	2015	Utilizing murine inducible telomerase alleles in the studies of tissue degeneration/regeneration and cancer.	PTEN
25964548		2015	Combining CAL-101 with Celecoxib Enhances Apoptosis of EBV-transformed B-Cells Through MAPK-induced ER Stress.	PTEN
26117013	10.7534/j.issn.1009-2137.2015.03.012	2015	[Expression and Clinical Pathological Significance of EBER, PTEN and VEGF in Angioimmunoblastic T-Cell Lymphoma].	PTEN
26141385	10.1016/j.mrfmmm.2015.06.004	2015	The effect of age at exposure on the inactivating mechanisms and relative contributions of key tumor suppressor genes in radiation-induced mouse T-cell lymphomas.	PTEN
26284558	10.1167/iovs.15-16757	2015	Reactivation of the PI3K/Akt Signaling Pathway by the Bisperoxovanadium Compound bpV(pic) Attenuates Photoreceptor Apoptosis in Experimental Retinal Detachment.	PTEN
26341754	10.1007/s00277-015-2474-0	2015	Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.	PTEN
26485928	10.1166/jbn.2015.2095	2015	Protecting Quantum Dot Fluorescence from Quenching to Achieve a Reliable Automated Multiplex Fluorescence In Situ Hybridization Assay.	PTEN
26579470	10.1016/j.apsb.2015.07.001	2015	Mechanisms of resistance to EGFR tyrosine kinase inhibitors.	PTEN
21426775		2014	[Anti-sense miRNA-21 oligonucleotide inhibits Tb 3.1 human tongue squamous cell carcinoma growth in vitro].	PTEN
23551855	10.1111/cas.12160	2014	Role of microRNA in the pathogenesis of malignant lymphoma.	PTEN
23823831		2014	Intrinsic determinants of optic nerve regeneration.	PTEN
23827971	10.1016/j.pneurobio.2013.06.002	2014	Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.	PTEN
23861962	10.1371/journal.pone.0069208	2014	Fate mapping for activation-induced cytidine deaminase (AID) marks non-lymphoid cells during mouse development.	PTEN
23888962	10.2174/13816128113199990528	2014	HDAC as a therapeutic target for treatment of endometrial cancers.	PTEN
24033376	10.1111/ics.12090	2014	Age-induced hair greying - the multiple effects of oxidative stress.	PTEN
24062018	10.1182/blood-2013-06-510578	2014	Comprehensive analysis of PTEN status in Sezary syndrome.	PTEN
24091535	10.4161/cc.26575	2014	PI3K/AKT addiction in subsets of diffuse large B-cell lymphoma.	PTEN
24140063	10.1016/j.bbrc.2013.10.034	2014	C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells.	PTEN
24140475	10.1016/j.cellsig.2013.09.021	2014	New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.	PTEN
24146019	10.4161/cbt.26604	2014	Neem leaf extract inhibits mammary carcinogenesis by altering cell proliferation, apoptosis, and angiogenesis.	PTEN
24166518	10.1200/JCO.2012.48.5292	2014	Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.	PTEN
24239354	10.1016/j.celrep.2013.10.022	2014	Context-specific BAFF-R signaling by the NF-κB and PI3K pathways.	PTEN
24253024	10.1038/leu.2013.349	2014	Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling.	PTEN
24291004	10.1016/j.ccr.2013.10.022	2014	Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia.	PTEN
24367090	10.1073/pnas.1213773111	2014	Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis.	PTEN
24384093	10.1016/j.canlet.2013.12.027	2014	Murine Pten(-/-) T-ALL requires non-redundant PI3K/mTOR and DLL4/Notch1 signals for maintenance and γc/TCR signals for thymic exit.	PTEN
24420742	10.1007/s00428-014-1535-4	2014	Prognostic and predictive biomarkers in lung cancer. A review.	PTEN
24425042	10.3892/mmr.2014.1892	2014	Α-eleostearic acid inhibits growth and induces apoptosis in breast cancer cells via HER2/HER3 signaling.	PTEN
24485662	10.1016/j.celrep.2014.01.007	2014	ZFX controls propagation and prevents differentiation of acute T-lymphoblastic and myeloid leukemia.	PTEN
24552990	10.1038/leu.2014.78	2014	Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia.	PTEN
24569712	10.1038/ncomms4393	2014	Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers.	PTEN
24700479	10.1002/cncr.28604	2014	Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: a prospective, single-institute study.	PTEN
24731550	10.1186/1750-9378-9-12	2014	The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma.	PTEN
24735967	10.1182/blood-2013-11-539411	2014	Premalignant PTEN-deficient thymocytes activate microRNAs miR-146a and miR-146b as a cellular defense against malignant transformation.	PTEN
24740809	10.1182/blood-2014-01-547695	2014	Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.	PTEN
24741074	10.1124/jpet.114.212910	2014	Inhibition of phosphatidylinositol 3-kinase/AKT signaling by NVP-BKM120 promotes ABT-737-induced toxicity in a caspase-dependent manner through mitochondrial dysfunction and DNA damage response in established and primary cultured glioblastoma cells.	PTEN
24762997	10.7534/j.issn.1009-2137.2014.02.009	2014	[Inducing effects of ursolic acid on Jurkat cell apoptosis and its mechanisms].	PTEN
24763002	10.7534/j.issn.1009-2137.2014.02.014	2014	[Expression and clinical significance of miR-21 in diffuse large B cell lymphoma].	PTEN
24832086	10.1093/carcin/bgu106	2014	Maternal metabolic perturbations elicited by high-fat diet promote Wnt-1-induced mammary tumor risk in adult female offspring via long-term effects on mammary and systemic phenotypes.	PTEN
24904117	10.1182/blood-2014-03-562751	2014	PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events.	PTEN
25505733	10.3389/fonc.2014.00329	2014	Promising Targets and Current Clinical Trials in Metastatic Non-Squamous NSCLC.	PTEN
22236332	10.1111/j.1476-5829.2011.00299.x	2013	Reading between the lines: molecular characterization of five widely used canine lymphoid tumour cell lines.	PTEN
22718117	10.1038/jid.2012.203	2013	NOTCH1 signaling as a therapeutic target in Sézary syndrome.	PTEN
22870330	10.1371/journal.pone.0042470	2013	Proteomic profiling of a mouse model for ovarian granulosa cell tumor identifies VCP as a highly sensitive serum tumor marker in several human cancers.	PTEN
22890838	10.1002/ijc.27774	2013	High-resolution genomic profiling reveals clonal evolution and competition in gastrointestinal marginal zone B-cell lymphoma and its large cell variant.	PTEN
23013295	10.3109/10428194.2012.733880	2013	Low expression level of phosphatase and tensin homolog deleted on chromosome ten predicts poor prognosis in chronic lymphocytic leukemia.	PTEN
23030661	10.1111/jre.12011	2013	p53-Pathway activity and apoptosis in hydrogen sulfide-exposed stem cells separated from human gingival epithelium.	PTEN
23134359	10.3109/10428194.2012.746685	2013	The phosphoinositide 3-kinase pathway in chronic lymphocytic leukemia: evidence for phosphatase and tensin homolog deletion on chromosome 10 deregulation.	PTEN
23183424	10.1038/leu.2012.316	2013	Differential roles of Kras and Pten in murine leukemogenesis.	PTEN
23196801	10.1292/jvms.12-0448	2013	Establishment of five canine lymphoma cell lines and tumor formation in a xenotransplantation model.	PTEN
23275230	10.1007/s12185-012-1256-x	2013	MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen.	PTEN
23336417		2013	[The expression and meanning of Skp2, p27, PTEN proteins in non-Hodgkin B-cell lymphoma of ocular adnexa].	PTEN
23341344	10.1002/gcc.22039	2013	The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.	PTEN
23344409	http://101097/AOG.0b013e318270444f	2013	Management of reproductive health in Cowden syndrome complicated by endometrial polyps and breast cancer.	PTEN
23348702	10.1016/j.canlet.2013.01.020	2013	Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas.	PTEN
23349303	10.3324/haematol.2012.073585	2013	NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.	PTEN
23373539	10.1111/bjh.12231	2013	KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia.	PTEN
23533410	10.1155/2013/897025	2013	Mammalian target of rapamycin inhibitors induce tumor cell apoptosis in vivo primarily by inhibiting VEGF expression and angiogenesis.	PTEN
23548551	10.1159/000346441	2013	Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma.	PTEN
23612073	10.1016/j.canlet.2013.04.015	2013	The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL/T-LL cancer cells.	PTEN
23637129	10.1182/blood-2012-05-432252	2013	Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo.	PTEN
23673656	10.1074/jbc.M113.475376	2013	Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation.	PTEN
23687664	10.5546/aap.2013.98	2013	Expression of concern from journal editor.	PTEN
23702245	10.1016/j.freeradbiomed.2013.05.014	2013	Cellular metabolic and autophagic pathways: traffic control by redox signaling.	PTEN
23715078	10.1097/DAD.0b013e318276cc68	2013	Expression of PTEN in mycosis fungoides and correlation with loss of heterozygosity.	PTEN
23764004	10.1016/j.ccr.2013.05.002	2013	SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas.	PTEN
23788636	10.1074/jbc.M113.451625	2013	Notch1 receptor regulates AKT protein activation loop (Thr308) dephosphorylation through modulation of the PP2A phosphatase in phosphatase and tensin homolog (PTEN)-null T-cell acute lymphoblastic leukemia cells.	PTEN
23801632	10.1182/blood-2012-12-471904	2013	β-Catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL.	PTEN
23840064	10.1073/pnas.1305656110	2013	PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma.	PTEN
24127490	10.1084/jem.20122768	2013	Pten loss in the bone marrow leads to G-CSF-mediated HSC mobilization.	PTEN
11908870	10.1007/BF02479427	2012	Primary malignant lymphoma of the brain: analysis of MMAC1 (PTEN) tumor suppressor gene.	PTEN
20960030	10.1007/s10637-010-9558-4	2012	Schedule-dependent inhibition of T-cell lymphoma cells by cotreatment with the mTOR inhibitor everolimus and anticancer drugs.	PTEN
21362248		2012	[Role of cytokines and gene expression characteristics in cultured lymphocytes ex vivo for adoptive immunotherapy].	PTEN
21524277	10.1042/CBI20110161	2012	Dispensable role of PTEN in mouse spermatogenesis.	PTEN
21819957	10.1016/j.ajpath.2011.06.017	2012	Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi's sarcoma.	PTEN
21857153	10.4161/cc.10.17.16959	2012	Cooperative control of tumor suppressor genes by a network of oncogenic microRNAs.	PTEN
21926961	10.1038/leu.2011.220	2012	Differential requirements for c-Myc in chronic hematopoietic hyperplasia and acute hematopoietic malignancies in Pten-null mice.	PTEN
21943825	10.1016/j.canlet.2011.08.023	2012	Inactivation of Rac1 reduces Trastuzumab resistance in PTEN deficient and insulin-like growth factor I receptor overexpressing human breast cancer SKBR3 cells.	PTEN
22032493	10.1186/1471-2180-11-240	2012	Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1.	PTEN
22116552	10.1038/leu.2011.305	2012	The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation.	PTEN
22137317	10.1016/j.leukres.2011.10.022	2012	Synergistic activity of rapamycin and dexamethasone in vitro and in vivo in acute lymphoblastic leukemia via cell-cycle arrest and apoptosis.	PTEN
22149168	10.3109/10428194.2011.647311	2012	Expression levels of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and focal adhesion kinase in patients with multiple myeloma and their relationship to clinical stage and extramedullary infiltration.	PTEN
22150431	10.1042/BJ20111741	2012	Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor.	PTEN
22158038	10.1038/onc.2011.566	2012	Mcm2 deficiency results in short deletions allowing high resolution identification of genes contributing to lymphoblastic lymphoma.	PTEN
22185283	10.3109/10428194.2011.650695	2012	Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.	PTEN
22220917	10.3109/10428194.2011.654340	2012	The role of phosphatase and tensin homolog deleted on chromosome 10 and focal adhesion kinase in aggressive multiple myeloma.	PTEN
22285507	10.1016/j.leukres.2011.12.018	2012	The study of resistant mechanisms and reversal in an imatinib resistant Ph+ acute lymphoblastic leukemia cell line.	PTEN
22287727		2012	Quantitative MRI establishes the efficacy of PI3K inhibitor (GDC-0941) multi-treatments in PTEN-deficient mice lymphoma.	PTEN
22357666	10.1124/mol.112.077586	2012	Lapatinib and obatoclax kill tumor cells through blockade of ERBB1/3/4 and through inhibition of BCL-XL and MCL-1.	PTEN
22488797	10.1002/pbc.24153	2012	ALK+ anaplastic large cell lymphoma exhibits phosphatidylinositol-3 kinase/Akt activity with retained but inactivated PTEN--a report from the Children's Oncology Group.	PTEN
22509484		2012	HTLV-I Tax regulates the cellular proliferation through the down-regulation of PIP3-phosphatase expressions via the NF-κB pathway.	PTEN
22516257	10.1016/j.ccr.2012.02.029	2012	Targeting nonclassical oncogenes for therapy in T-ALL.	PTEN
22611241	10.4049/jimmunol.1102116	2012	Pten loss in CD4 T cells enhances their helper function but does not lead to autoimmunity or lymphoma.	PTEN
22675565	10.1371/journal.pone.0038463	2012	High accuracy mutation detection in leukemia on a selected panel of cancer genes.	PTEN
22715338	10.3389/fimmu.2012.00151	2012	Regulation of T cell homeostasis and responses by pten.	PTEN
22908014	10.3389/fimmu.2012.00224	2012	The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions.	PTEN
22956625	10.1258/ebm.2012.012075	2012	Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia.	PTEN
23264848	10.1177/1947601912463695	2012	CtBP2 Promotes Human Cancer Cell Migration by Transcriptional Activation of Tiam1.	PTEN
20165695	10.1593/tlo.09244	2011	Differential Effects of the Proteasome Inhibitor NPI-0052 against Glioma Cells.	PTEN
20233282	10.1111/j.1743-6109.2010.01724.x	2011	Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats.	PTEN
20517718	10.1007/82_2010_71	2011	PI3K as a target for therapy in haematological malignancies.	PTEN
20624167	10.1111/j.1349-7006.2010.01637.x	2011	Sprouty2 protein enhances the response to gefitinib through epidermal growth factor receptor in colon cancer cells.	PTEN
20956280	10.1136/bjo.2010.183939	2011	Expression of HSP 90, PTEN and Bcl-2 in conjunctival melanoma.	PTEN
21040528	10.1186/1748-717X-5-100	2011	MicroRNA-17-92 significantly enhances radioresistance in human mantle cell lymphoma cells.	PTEN
21212363	10.1073/pnas.1006937108	2011	Suppression of leukemia development caused by PTEN loss.	PTEN
21407213	10.1038/bjc.2011.83	2011	Effect of PI3K- and mTOR-specific inhibitors on spontaneous B-cell follicular lymphomas in PTEN/LKB1-deficient mice.	PTEN
21455568	10.3892/ijo.2011.984	2011	The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis.	PTEN
21463127	10.3109/10428194.2011.564696	2011	NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia.	PTEN
21464223	10.1084/jem.20110105	2011	Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse.	PTEN
21527520	10.1182/blood-2011-02-336842	2011	Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia.	PTEN
21642990	10.1038/ng.858	2011	A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL).	PTEN
21727187	10.1084/jem.20101691	2011	Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia.	PTEN
21763505	10.1016/j.jmb.2011.03.055	2011	Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi's-sarcoma-associated herpesvirus: role of Ras/c-Raf/MEK1/2, PI3K/AKT, and NF-κB signaling pathways.	PTEN
21816922	10.1101/gad.17027411	2011	miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma.	PTEN
19723646	10.1158/1078-0432.CCR-08-3215	2010	Phosphatidylinositol 3'-kinase catalytic subunit alpha gene amplification contributes to the pathogenesis of mantle cell lymphoma.	PTEN
19829307	10.1038/leu.2009.209	2010	Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia.	PTEN
19884659	10.1172/JCI39374	2010	The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells.	PTEN
20008304	10.1182/blood-2009-04-214718	2010	Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss.	PTEN
20008787	10.1182/blood-2009-06-229443	2010	Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice.	PTEN
20015880	10.3324/haematol.2009.011999	2010	Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors.	PTEN
20060398	10.1016/j.mrfmmm.2009.12.011	2010	Complicated biallelic inactivation of Pten in radiation-induced mouse thymic lymphomas.	PTEN
20124220	10.1182/blood-2009-07-234377	2010	Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.	PTEN
20127010	10.3892/or_00000688	2010	4-Chlorobenzoyl berbamine induces apoptosis and G2/M cell cycle arrest through the PI3K/Akt and NF-kappaB signal pathway in lymphoma cells.	PTEN
20190740	10.1038/ncb2037	2010	Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.	PTEN
20354178	10.1158/0008-5472.CAN-09-4072	2010	The antidepressant sertraline inhibits translation initiation by curtailing mammalian target of rapamycin signaling.	PTEN
20384580	10.2174/156800910791517172	2010	The mTOR pathway: a new target in cancer therapy.	PTEN
20516645	10.1172/JCI42382	2010	Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice.	PTEN
20628151	10.1182/blood-2010-03-276857	2010	Multiple signaling pathways induced by hexavalent, monospecific, anti-CD20 and hexavalent, bispecific, anti-CD20/CD22 humanized antibodies correlate with enhanced toxicity to B-cell lymphomas and leukemias.	PTEN
20679220	10.1073/pnas.1008136107	2010	Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development.	PTEN
20800819	10.1016/S1877-1173(10)92006-1	2010	Early T cell differentiation lessons from T-cell acute lymphoblastic leukemia.	PTEN
20807096	10.3109/10428194.2010.502584	2010	PTEN tumor suppressor plays less prognostic role than P53 tumor suppressor in diffuse large B-cell lymphoma.	PTEN
20956547	10.1084/jem.20091962	2010	Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases.	PTEN
18728972	10.1080/08880010802237054	2009	Immunohistochemical analyses of phosphatases in childhood B-cell lymphoma: lower expression of PTEN and HePTP and higher number of positive cells for nuclear SHP2 in B-cell lymphoma cases compared to controls.	PTEN
18830414	10.1172/JCI34616	2009	PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability.	PTEN
19206008	10.1080/08880010802625530	2009	Expression of PTEN and SHP1, investigated from tissue microarrays in pediatric acute lymphoblastic, leukemia.	PTEN
19340001	10.1038/leu.2009.64	2009	The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	PTEN
19373662	10.1080/10428190902755505	2009	Upregulation of PTEN involved in scorpion venom-induced apoptosis in a lymphoma cell line.	PTEN
19412536	10.1371/journal.pone.0005428	2009	Altering chemosensitivity by modulating translation elongation.	PTEN
19458356	10.1182/blood-2009-02-206722	2009	High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.	PTEN
19473701	10.1016/j.leukres.2009.04.032	2009	Inactivation of SHIP1 in T-cell acute lymphoblastic leukemia due to mutation and extensive alternative splicing.	PTEN
19508975	10.3324/haematol.2009.006718	2009	Physiological PTEN expression in peripheral T-cell lymphoma not otherwise specified.	PTEN
19517471	10.1002/cncr.24430	2009	Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas.	PTEN
19608668	10.3324/haematol.2009.007260	2009	Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1/beta-catenin genes in human herpesvirus 8-associated primary effusion lymphoma.	PTEN
19641183	10.1182/blood-2009-06-222794	2009	Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia.	PTEN
19667415		2009	Molecular genetic analysis of a primitive neuroectodermal tumor arising after intracranial radiation and chemotherapy for leukemia.	PTEN
20008935	10.1101/gad.1861409	2009	miR-19 is a key oncogenic component of mir-17-92.	PTEN
18339899	10.1182/blood-2007-07-103481	2008	Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma.	PTEN
18599181	10.1016/j.exphem.2008.04.011	2008	Resistance to TRAIL-induced apoptosis caused by constitutional phosphorylation of Akt and PTEN in acute lymphoblastic leukemia cells.	PTEN
17657213	10.1038/sj.leu.2404873	2007	PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma.	PTEN
17895757	10.1097/PAS.0b013e3180408d76	2007	Loss of heterozygosity analysis identifies genetic abnormalities in mycosis fungoides and specific loci associated with disease progression.	PTEN
15717329	10.1002/pmic.200401046	2005	Analysis of phosphatase and tensin homolog tumor suppressor interacting proteins by in vitro and in silico proteomics.	PTEN
16194892	10.1080/10428190500144813	2005	PTEN and p27 expression in mature T-cell and NK-cell neoplasms.	PTEN
14559824		2003	PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.	PTEN
11932928	10.1002/1521-4141(200204)32:4&lt;1196::AID-IMMU1196&gt;3.0.CO;2-K	2002	The phosphatidylinositol phosphatase PTEN is under control of costimulation and regulates proliferation in human T cells.	PTEN
10092130		1999	Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas.	PTEN
